GTC
Ghost Tree Capital’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.71M | Sell |
75,000
-512,708
| -87% | -$11.7M | 0.52% | 45 |
|
|
2024
Q2 | $7.65M | Sell |
587,708
-37,292
| -6% | -$485K | 2.39% | 14 |
|
|
2024
Q1 | $10.9M | Buy |
625,000
+325,000
| +108% | +$5.69M | 3.03% | 7 |
|
|
2023
Q4 | $6.53M | Buy |
300,000
+25,000
| +9% | +$545K | 2.14% | 6 |
|
|
2023
Q3 | $4.22M | Buy |
275,000
+35,000
| +15% | +$537K | 1.39% | 17 |
|
|
2023
Q2 | $5.71M | Buy |
240,000
+65,000
| +37% | +$1.55M | 1.88% | 19 |
|
|
2023
Q1 | $4.45M | Buy |
175,000
+10,000
| +6% | +$254K | 1.32% | 26 |
|
|
2022
Q4 | $4.82M | Sell |
165,000
-370,000
| -69% | -$10.8M | 2.06% | 19 |
|
|
2022
Q3 | $11M | Sell |
535,000
-65,000
| -11% | -$1.33M | 3.08% | 9 |
|
|
2022
Q2 | $6.94M | Buy |
600,000
+133,597
| +29% | +$1.55M | 3.62% | 10 |
|
|
2022
Q1 | $8.62M | Sell |
466,403
-33,597
| -7% | -$621K | 1.87% | 8 |
|
|
2021
Q4 | $9.89M | Buy |
500,000
+150,000
| +43% | +$2.97M | 3.54% | 8 |
|
|
2021
Q3 | $5.76M | Hold |
350,000
| – | – | 1.68% | 18 |
|
|
2021
Q2 | $6.4M | Buy |
350,000
+50,000
| +17% | +$915K | 1.76% | 18 |
|
|
2021
Q1 | $5.01M | Buy |
+300,000
| New | +$5.01M | 1.18% | 29 |
|